KIMS: A play on healthcare demand in the hinterland
The recent expansion tilt towards tier 2/3 cities suggests that this may garner decent volume growth, though possibly at the cost of margins07-04-2022
07-04-2022
Krishna Institute of Medical Sciences Ltd - 543308 - Closure of Trading Window
Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 201530-03-2022
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Company is having a Investors conference organized by Motilal Oswal Financial Services Limited on 24th March, 202223-03-2022
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analysts and Investors virtual meeting with various investors/ Analysts15-03-2022
Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.`
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 15, 2022 for Bollineni Seenaiah Naidu15-03-2022
Buy Krishna Institute of Medical Sciencesg; target of Rs 1776: Khambatta Securities
Khambatta Securities is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1776 in its research report dated March 14, 2022.14-03-2022
Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 22, 2022 for Bhaskara Rao Bollineni22-02-2022
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Company had organized a conference call with the Investors/ Analysts on Thursday, 10 February 2022 at 6:00 pm (IST). A copy of Transcript of conference call held with the Investors/ Analysts is enclosed herewith and the same has also been uploaded on the Company''s Website at https://www.kimshospitals.com/stakeholder-relations/Financial Results, Investors PPT, Press Release & Financial Press Ad/ Call Recordings and Transcripts14-02-2022
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company submits copy of newspaper advertisement of the Un-audited Financial Results of the company for the 2nd Quarter and Half year ended 30th September 2021 published on 11th November, 2021 in Financial Express (English) and Nava Telangana (Telugu).12-02-2022
Q3FY22 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Healthcare Facilities firm Krishna Institute of Medical Sciences declares Q3FY22 result: Consolidated Total Income & EBITDA grew by 10% & 42% respectively for Q3 FY 21-22 as compared to Q3 FY 20-21 The current quarter, Q3 FY 22 saw the business coming back on track to pre Covid levels. For Q3 FY 22, Total Income was Rs. 3960 mn, EBITDA was at 1322 mn and PAT was at Rs. 842 mn 9M FY22 revenue and EBITDA growth are partly on account of the low base during the last financial year due to lockdown, which makes 9M FY21, not a comparable period. Commenting on the performance, Dr. B. Bhaskara Rao, Managing Director said: “Q3 has been a busy quarter for the hospital sector. With COVID wave ebbing, the footfalls at OPD as well as high end elective surgery work have now come back to near pre Covid levels. We are fairly confident now that India has successfully navigated the current Covid challenge, new variants notwithstanding. We are optimistic that the business momentum seen across all our units will be on course for the set growth trajectory. I am happy to note that a lot of challenging medical work got done in this quarter, including India’s first Breathing Lung transplant.” Result PDF10-02-2022